ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

Trastuzumab is an effective therapeutic treatment for Her2-like breast cancer; despite this most of these tumors develop resistance to therapy due to specific gene mutations or alterations in gene expression. Understanding the mechanisms of resistance to Trastuzumab could be a useful tool in order t...

Descripción completa

Detalles Bibliográficos
Autores principales: La Ferla, Marco, Lessi, Francesca, Aretini, Paolo, Pellegrini, Davide, Franceschi, Sara, Tantillo, Elena, Menicagli, Michele, Marchetti, Ivo, Scopelliti, Claudia, Civita, Prospero, De Angelis, Claudia, Diodati, Lucrezia, Bertolini, Ilaria, Roncella, Manuela, McDonnell, Liam A., Hochman, Jacob, Del Re, Marzia, Scatena, Cristian, Naccarato, Antonio G., Fontana, Andrea, Mazzanti, Chiara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607964/
https://www.ncbi.nlm.nih.gov/pubmed/31297336
http://dx.doi.org/10.3389/fonc.2019.00547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607964/
https://www.ncbi.nlm.nih.gov/pubmed/31297336
http://dx.doi.org/10.3389/fonc.2019.00547

Ejemplares similares